Margareta Fridström
Karolinska Institutet
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Margareta Fridström.
Prenatal Diagnosis | 2000
Erik Iwarsson; Helena Malmgren; José Inzunza; Lars Ährlund-Richter; Peter Sjöblom; Björn Rosenlund; Margareta Fridström; Outi Hovatta; Magnus Nordenskjöld; Elisabeth Blennow
We have developed preimplantation genetic diagnosis (PGD) for carriers of chromosomal abnormalities using fluorescent in situ hybridisation (FISH). Here we present the detailed analysis of 64 biopsied, normally developing embryos obtained from four Robertsonian and three reciprocal translocation carriers in 11 treatment cycles of which four resulted in normal pregnancies (three simplex, one duplex). In order to investigate the degree of mosaicism and segregation mode in the embryos, the primary analysis of the biopsied cells was extended with the analysis of all cells from the non‐transferred embryos. The analysis also included a second hybridisation with two additional probes, not involved in the translocation (chromosomes 1 and 9), in order to investigate the overall degree of mosaicism. Seventeen out of 64 analysed embryos were balanced for the chromosomes involved in the translocation and 14 of these were transferred. Forty‐seven out of 64 embryos (73%) were mosaic regarding the chromosomes involved in the translocation and alternate segregation mode was the most common mode of segregation. Moreover, we have found a higher degree of mosaicism for the chromosomes involved in translocations as compared to control chromosomes. This difference was more pronounced for the embryos from reciprocal translocation carriers. The results, mechanisms, significance and implications of our findings are discussed. Copyright
Hypertension in Pregnancy | 1999
Margareta Fridström; Henry Nisell; Peter Sjöblom; Torbjörn Hillensjö
OBJECTIVE To study whether there is an increased risk of glucose intolerance and hypertensive complications during pregnancy in women with polycystic ovary syndrome (PCOS) and if there is an adverse pregnancy outcome. METHODS In a retrospective case-control study, pregnancies and neonatal outcome were compared in 33 women with PCOS and 66 women without PCOS. The women were treated at Huddinge University Hospital; antenatal care was given at associated outpatient units. MAIN OUTCOME MEASURES Blood glucose and blood pressure during the different trimesters. Pregnancy outcome in terms of gestational length, birth weight, and need for neonatal intensive care. RESULTS No significant differences were found in blood glucose levels between the groups. There were also no differences in blood pressure during the first and second trimester. However, during the third trimester and labor, the PCOS group had a significantly higher blood pressure than the control group. Apart from a tendency toward reduced growth of twins in PCOS mothers, the babies were healthy, overall, with few problems in the neonatal period. CONCLUSIONS No major differences with regard to perinatal outcome in pregnant women with and without PCOS were found. An increased risk of hypertensive disorders in the third trimester and during labor was demonstrated in the PCOS group. This suggests that in the antenatal care of women with PCOS, attention should focus on blood pressure in order to reduce the risks of morbidity associated with hypertension.
Prenatal Diagnosis | 1998
José Inzunza; Erik Iwarsson; Margareta Fridström; Björn Rosenlund; Peter Sjöblom; Torbjörn Hillensjö; Elisabeth Blennow; B. Jones; Magnus Nordenskjöld; I. Ährlund-Richter
We have tested and subsequently successfully applied a single‐needle approach to obtain blastomere biopsies from human preimplantation embryos for preimplantation genetic diagnosis (PGD).
Acta Obstetricia et Gynecologica Scandinavica | 1995
Margareta Fridström; Leena Garoff; Peter Sjöblom; Torbjörn Hillensjö
Background. Assisted reproduction implies increased risks of pathological pregnancy, necessitating close follow up of early pregnancy. The use of serum hCG levels two and three weeks after embryo transfer for prediction of pregnancy outcome after in vitro fertilization‐embryo transfer (IVF/ET) or gamete intrafallopian transfer (GIFT) was evaluated.
Acta Obstetricia et Gynecologica Scandinavica | 2003
Kerstin Bjuresten; Julius Hreinsson; Margareta Fridström; Björn Rosenlund; Ingvar Ek; Outi Hovatta
Background. Embryo transfer (ET) in assisted reproduction treatments has traditionally been performed by gynecologists in the Nordic countries. As gynecologists often have a busy schedule, midwives and nurses have become increasingly important in performing the treatment, providing subject information, ultrasound monitoring and assistance at ET.
Acta Obstetricia et Gynecologica Scandinavica | 1999
Margareta Fridström; Peter Sjöblom; Maria E. Granberg; Torbjörn Hillensjö
BACKGROUND The study compares treatment outcome and costs of ovulation induction cycles and in vitro fertilization cycles in infertile women with clomiphene resistant polycystic ovary syndrome. METHODS Twenty-eight infertile women with clomiphene resistant polycystic ovary syndrome referred to a university clinic were prospectively randomized to ovulation induction or in vitro fertilization. Forty-one ovulation induction cycles and thirty in vitro fertilization cycles were performed. Mann-Whitney U-test was used for between group comparisons and frequencies were compared with Fishers exact test. RESULTS More pregnancies per completed cycle were noted in the in vitro fertilization group than in the ovulation induction group. Drug costs were not much higher in the in vitro fertilization group but treatment costs were higher due to the additional costs of ovum pick up and embryo transfer. The cost per pregnancy was about twice as high in the ovulation induction group as in the in vitro fertilization group. The cost per term pregnancy including delivery was 1.6 times higher in the ovulation induction group. CONCLUSION For a group of obese women with clomiphene resistant polycystic ovary syndrome, in vitro fertilization seems a cost-effective treatment.
Acta Obstetricia et Gynecologica Scandinavica | 1988
A. Lagrelius; Margareta Fridström; Gunnar Möllerström; Kjell Carlström
Concentrations of dehydroepiandrosterone sulfate (DHAS) in saliva and serum were determined in 11 healthy men aged 23–40yrs. 55 healthy, non‐medicated women aged 20–81 yrs and 13 healthy women aged 20–30 yrs, all taking combined oral contraceptives (OC). Serum DHAS was higher in men than in women of corresponding age and was negatively correlated to age in OC‐free women. These sex‐ and age‐related differences were not found for salivary DHAS. Salivary and serum DHAS values were poorly correlated and the ratios between salivary and serum DHAS were variable, with a tendency to higher values in older subjects. Low salivabrum DHAS ratios were found in OC users. The lack of a uniform, unequivocal relation between DHAS concentrations in saliva and serum renders salivary DHAS assays unsuitable for clinical purposes.
Human Reproduction | 2007
Victoria Keros; Kjell Hultenby; Birgit Borgström; Margareta Fridström; Kirsi Jahnukainen; Outi Hovatta
The Journal of Clinical Endocrinology and Metabolism | 2002
Julius Hreinsson; Marjut Otala; Margareta Fridström; Birgit Borgström; Carsten Rasmussen; Monalill Lundqvist; Timo Tuuri; Niklas Simberg; Milla Mikkola; Leo Dunkel; Outi Hovatta
Molecular Human Reproduction | 1998
Erik Iwarsson; Lars Ährlund-Richter; José Inzunza; Björn Rosenlund; Margareta Fridström; Torbjörn Hillensjö; Peter Sjöblom; Magnus Nordenskjöld; Elisabeth Blennow